U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630363) titled 'PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC' on June 01.
Brief Summary: Given the significant challenge of drug resistance in patients with advanced renal cell carcinoma (RCC) despite standard treatment, this study aims to translate preclinical findings into clinical practice, preliminarily evaluating the safety, tolerability, and preliminary efficacy of atorvastatin calcium combined with targeted and immunotherapy in patients with advanced RCC. We hypothesize that for some patients with advanced RCC who do not respond well to targeted + immunotherapy, identifying potential beneficiaries based on their PTC s...